June 14, 2021
Kentucky & Ohio Joint Teleconference/Webinar Open Public Draft/Revised LCD Discussion Meeting: July 13th, 2021 – Revised 06/16/2021
CGS will host a Joint Kentucky & Ohio Open Meeting Teleconference/Webinar for comments from providers and the general public related to the development of Local Coverage Determinations (LCDs) for Medicare Jurisdiction15.
Date: | July 13th, 2021 |
Time: | 3:30-5:30 P.M. EDT |
Place: | Teleconference/Webinar |
Please note that this is the Open Public meeting to discuss Draft LCDs or Revisions to current LCDs and not the Contractor Advisory Committee Meetings (CAC).
Please use the following Webinar Registration link to sign up (note: you must register to attend via teleconference/webinar). Dial in information will be provided after registration.
The following draft LCD(s) will be discussed:
3:30 – 4:30 PM
- DL39015 – Epidural Procedures for Pain Management
- DL38016 – MolDX: Melanoma Risk Stratification Molecular Testing
- DL39017 – MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes
- DL39038 – MolDX: Multiplex Nucleic Acid Amplification Test (NAAT) Panels for Infectious Disease Testing
- DL38997 – MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
4:30 – 5:30 PM
- DL38992 – Electroretinography
- DL39023 – Platelet Rich Plasma Injections for Non-Wound Injections
Link to the Draft LCDs: Kentucky Proposed/Draft LCDs Not Released to Final
Link to the Draft LCDs: Ohio Proposed/Draft LCDs Not Released to Final
NOTE: The drafts will not be available for viewing on the CMS MCD Database until 06/24/2021.
Interested parties who wish to make presentations related to the draft LCD must submit a written request no later than 07/03/2021 (Note: Time extended from 06/29/2021 due to drafts not being available to view until 06/24/2021) to CMD.Inquiry@cgsadmin.com and include the following information:
- Name, address, telephone number and e-mail address of presenter
- Name, address, telephone number and e-mail address of organization
- Name of draft LCD
- Copy of the presentation(s)
- Completed Conflict of Interest (COI) Form for each topic you wish to present
If you wish to present on a Draft LCD, please select and complete the Consent Form from the PDFs below:
- DL38016 – MolDX: Melanoma Risk Stratification Molecular Testing
- DL38992 – Electroretinography
- DL38997 – MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- DL39015 – Epidural Procedures for Pain Management
- DL39017 – MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes
- DL39023 – Platelet Rich Plasma Injections for Non-Wound Injections
- DL39038 – MolDX: Multiplex Nucleic Acid Amplification Test (NAAT) Panels for Infectious Disease Testing
The presentation and COI form must be attached to your request(s). Each presenter will have equal time based on the number of presentations requested. Once all requests are received, we will notify each presenter of the time allocation via email approximately one week prior to the meeting.
Future Meetings
Onsite meetings are tentative due to COVID-19; could be changed to joint teleconference/webinar.
- Kentucky Onsite – Tuesday, October 12th, 2021
- Ohio Onsite – Wednesday, October 13th, 2021